Statements of Cash Flows - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (6,051,790)	$ 11,627,209
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	3,843,500	(14,284,500)
Loss on issuance of private placement warrants	1,323,000
Financing cost - derivative warrant liabilities	783,506
Interest earned on investments held in Trust Account	(189)	(23,003)
Changes in operating assets and liabilities:
Prepaid expenses	(555,410)	291,217
Accounts payable	16,981	325,557
Accrued expenses		933,760
Franchise tax payable	57,036	117,058
Net cash used in operating activities	(583,366)	(1,012,702)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from note payable to related party	150,000
Repayment of note payable to related party	(150,000)
Proceeds received from initial public offering, gross	230,000,000
Proceeds received from private placement	7,350,000
Offering costs paid	(5,067,280)
Net cash provided by financing activities	232,307,720
Net change in cash	1,724,354	(1,012,702)
Cash - beginning of the period		1,724,354
Cash - end of the period	1,724,354	711,652
Supplemental disclosure of noncash activities:
Offering costs included in accrued expenses	70,000
Deferred underwriting commissions in connection with the initial public offering	$ 8,050,000